BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,138 filers reported holding BAXTER INTL INC in Q4 2019. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $425,405 | +9.5% | 11,272 | +32.1% | 0.00% | 0.0% |
| Q2 2023 | $388,672 | -86.8% | 8,531 | -88.3% | 0.00% | -85.7% |
| Q1 2023 | $2,946,035 | +37.3% | 72,634 | +72.6% | 0.01% | +16.7% |
| Q4 2022 | $2,145,276 | -17.4% | 42,089 | -12.7% | 0.01% | +9.1% |
| Q3 2022 | $2,597,000 | -75.0% | 48,220 | -70.6% | 0.01% | -42.1% |
| Q2 2022 | $10,373,672 | +299.4% | 163,998 | +389.8% | 0.02% | +280.0% |
| Q1 2022 | $2,597,000 | -70.8% | 33,485 | -67.7% | 0.01% | -73.7% |
| Q4 2021 | $8,902,000 | +50.1% | 103,700 | +40.6% | 0.02% | +46.2% |
| Q3 2021 | $5,931,000 | +141.5% | 73,743 | +141.7% | 0.01% | +116.7% |
| Q2 2021 | $2,456,000 | +40.7% | 30,506 | +47.4% | 0.01% | +50.0% |
| Q1 2021 | $1,745,000 | -22.3% | 20,691 | -26.1% | 0.00% | -20.0% |
| Q4 2020 | $2,247,000 | -79.0% | 28,000 | -79.0% | 0.01% | -80.8% |
| Q3 2020 | $10,701,000 | +149.4% | 133,064 | +167.0% | 0.03% | +85.7% |
| Q2 2020 | $4,291,000 | +101.9% | 49,833 | +90.4% | 0.01% | +7.7% |
| Q1 2020 | $2,125,000 | -75.3% | 26,171 | -74.5% | 0.01% | -70.5% |
| Q4 2019 | $8,591,000 | +52.5% | 102,737 | +59.5% | 0.04% | +22.2% |
| Q3 2019 | $5,633,000 | -50.3% | 64,400 | -53.5% | 0.04% | -52.6% |
| Q2 2019 | $11,335,000 | -11.4% | 138,410 | -12.1% | 0.08% | +1.3% |
| Q1 2019 | $12,798,000 | +24.6% | 157,400 | +0.9% | 0.08% | +15.4% |
| Q4 2018 | $10,269,000 | +21.5% | 156,019 | +42.2% | 0.06% | +75.7% |
| Q3 2018 | $8,455,000 | – | 109,684 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
| SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
| Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
| Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
| HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
| Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
| 13D Management LLC | 200,318 | $14,791,000 | 3.77% |
| ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
| Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |